The store will not work correctly when cookies are disabled.
4-(1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide
ID: ALA4474459
PubChem CID: 141143841
Max Phase: Preclinical
Molecular Formula: C15H11F2N5O3S
Molecular Weight: 379.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NS(=O)(=O)c1ccc(Nc2ncn(C(=O)c3c(F)cccc3F)n2)cc1
Standard InChI: InChI=1S/C15H11F2N5O3S/c16-11-2-1-3-12(17)13(11)14(23)22-8-19-15(21-22)20-9-4-6-10(7-5-9)26(18,24)25/h1-8H,(H,20,21)(H2,18,24,25)
Standard InChI Key: HTFSQZHIWGSTMP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
9.4018 -11.6181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9974 -10.9124 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5884 -11.6156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7100 -9.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7088 -10.5061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4169 -10.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1265 -10.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1237 -9.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4151 -9.2777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8298 -9.2717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5391 -9.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6312 -10.4889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4312 -10.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8372 -9.9465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2880 -9.3414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6495 -9.8580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1324 -10.5173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9790 -9.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7915 -9.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1211 -8.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6380 -7.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8217 -7.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4960 -8.4573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6840 -8.5494 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.2726 -9.6863 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.2934 -10.5050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 11 2 0
14 16 1 0
16 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
23 24 1 0
19 25 1 0
5 2 1 0
2 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.35 | Molecular Weight (Monoisotopic): 379.0551 | AlogP: 1.64 | #Rotatable Bonds: 4 |
Polar Surface Area: 119.97 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.01 | CX Basic pKa: ┄ | CX LogP: 1.78 | CX LogD: 1.76 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -1.73 |
References
1. Jorda R, Hendrychová D, Voller J, Řezníčková E, Gucký T, Kryštof V.. (2018) How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?, 61 (20): [PMID:30234987] [10.1021/acs.jmedchem.8b00049] |